Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Cal Gary who wrote (7629)	8/21/2001 10:01:54 AM
From: Cal Gary	Respond to of 14101

Duh-ha?!? Globe says Dimethaid moves up two days in a row Dimethaid Research Inc DMX Shares issued 42,388,090 2001-08-20 close $6.6 Tuesday Aug 21 2001 In the News The Globe and Mail reports in its Tuesday, Aug. 21, edition that Dimethaid Research rose 13 per cent or 75 cents to $6.60 on the Toronto Stock Exchange Monday. The Globe's Market Movers column reports that the pharmaceutical company rose for a second day after saying its loss for 2001 narrowed slightly to $13.74-million or 33 cents a share, from $13.75 million or 34 cents a year earlier. Quarterly results were not disclosed, says The Globe. Dimethaid stock is down from a 52-week high of $9.20 set in January and up from a 52-week low of $3.50 set in November. (c) Copyright 2001 Canjex Publishing Ltd. canada-stockwatch.com